Inhaler technique in Paediatric Asthma Patients V1

  • Research type

    Research Study

  • Full title

    A cross sectional, observational study to better understand inhaler technique and training in paediatric asthma patients in the community setting in Essex, UK.

  • IRAS ID

    360846

  • Contact name

    Matthew Osborne

  • Contact email

    mosborne@essex.ac.uk

  • Sponsor organisation

    University of Essex

  • Duration of Study in the UK

    0 years, 2 months, 15 days

  • Research summary

    A cross sectional, observational study to better understand inhaler technique and training in paediatric asthma
    patients in the community setting in Essex, UK.

    Asthma remains the most common long term medical condition in children and young people. Asthma affects the
    airways causing inflammation which is treated with inhaled medications, such as Corticosteroids. The correct use of
    the devices used to deliver inhaled medication is vital for treatment to be effective. The goal of treatment is to bring
    asthma symptoms under control. Poor asthma control increases the risk of poor outcomes, acute asthma
    exacerbations, and death.

    Devices used for asthma medications include metered dose inhalers (MDI) and dry powder inhalers (DPI). It is
    recommended that a spacer is used with MDI devices.

    Experience shows that children with uncontrolled asthma symptoms often have sub optimal inhaler technique.
    Consideration should be given as to why inhaler technique is often sub optimal. When the child is prescribed asthma
    medication, is any instruction or training given to the parent/child? If so, who delivers this training/instruction and are
    they given any training themselves?

    Survey method will be used to gather data from the parents/carers of children who have been prescribed asthma
    medication. Parents will be recruited at face to face clinics held in the community setting. It is hoped to enrol
    parent/carers of children with asthma, suspected asthma and viral induced wheeze. Sample size is estimated at 90
    out of a possible 240. This will allow for missed or cancelled appointments and refusal or inability to participate.

    The study will last for 6 weeks. Participants will be given written information about the study and informed, written
    consent will be sought. Three paediatric nursing colleagues have agreed to assist with data collection.

  • REC name

    London - West London & GTAC Research Ethics Committee

  • REC reference

    25/PR/0968

  • Date of REC Opinion

    21 Nov 2025

  • REC opinion

    Further Information Favourable Opinion